변비 치료제 시장 규모, 점유율, 성장 분석, 치료 유형별, 투여 경로별, 환자 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)

Global Constipation Treatment Market size was valued at USD 18.2 billion in 2023 and is poised to grow from USD 19.31 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The global constipation treatment market is experiencing significant growth driven by several key factors. The increasing geriatric population contributes to a higher incidence of chronic constipation and gastrointestinal disorders, while the rising use of opioids has led to a surge in opioid-induced constipation cases. Additionally, there is a notable shift toward over-the-counter remedies as consumers become more aware of gut health through various online platforms. The integration of technology, including digital health tracking and teleconsultation, is facilitating better diagnosis and management options. However, barriers such as long-term laxative use, low awareness in underserved areas, high prices for new treatments, and regulatory challenges pose obstacles to widespread access and sustained market advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Constipation Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Constipation Treatment Market Segments Analysis

Global Constipation Treatment Market is segmented by Treatment Type, Route of Administration, Patient Type, Distribution Channel and region. Based on Treatment Type, the market is segmented into Pharmacological and Non-Pharmacological. Based on Route of Administration, the market is segmented into Oral, Rectal and Parenteral / Sub-cutaneous. Based on Patient Type, the market is segmented into Adults, Pediatrics and Geriatrics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Constipation Treatment Market

One of the key market drivers for the Global Constipation Treatment Market is the rising prevalence of constipation due to lifestyle changes and dietary habits. Increased consumption of processed foods, coupled with sedentary lifestyles, has led to a growing number of individuals experiencing digestive issues. Furthermore, there is heightened awareness and acceptance of digestive health, prompting more individuals to seek medical advice and treatment options. This trend has driven demand for a variety of constipation treatments, including over-the-counter laxatives, prescription medications, and alternative therapies, fundamentally reshaping the landscape of gastrointestinal health management in the global market.

Restraints in the Global Constipation Treatment Market

One significant market restraint for the global constipation treatment market is the growing preference for natural and lifestyle-based remedies over conventional pharmaceutical options. Many consumers are increasingly aware of the side effects associated with over-the-counter laxatives and prescription medications, often opting instead for dietary changes, probiotics, and herbal supplements. This shift in consumer behavior poses a challenge for pharmaceutical companies, as the demand for traditional medications may decline. Additionally, the lack of awareness regarding the availability of various treatment options can further limit market growth, hindering potential revenue generation within the pharmaceutical sector focused on constipation relief.

Market Trends of the Global Constipation Treatment Market

The Global Constipation Treatment market is witnessing a trend towards personalized gut health solutions, driven by advancements in microbiome research and the integration of AI technology. This shift emphasizes tailored treatments that consider individual gut microbiomes, lifestyle factors, and dynamic symptom tracking, enhancing therapeutic efficacy and improving patient adherence. As healthcare increasingly prioritizes customized approaches, the market is evolving to incorporate innovative, data-driven methodologies that facilitate better management of constipation. This movement towards personalization not only optimizes treatment outcomes but also reflects broader trends in patient-centric care, ultimately reshaping the landscape of constipation management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Constipation Treatment Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Pharmacological
  • Laxatives
  • Chloride Channel Activators
  • GC-C Agonists
  • 5-HT4 Agonists
  • Peripherally Acting µ-Opioid Receptor Antagonists
  • Others
• Non-Pharmacological
  • Dietary Fiber Supplements
  • Biofeedback & Physical Therapy
  • Fecal Microbiota Transplant
  • Digital Therapeutics

Global Constipation Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Rectal
• Parenteral / Sub-cutaneous

Global Constipation Treatment Market Size by Patient Type & CAGR (2025-2032)

• Market Overview
• Adults
• Pediatrics
• Geriatrics

Global Constipation Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Constipation Treatment Market Size & CAGR (2025-2032)

• North America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ironwood Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shionogi & Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardelyx Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmo Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B. Fleet Company Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations